Clipping of news on Brazilian Culture, Law and Citizenship
 


Consumer News

Anvisa determines seizure of anorectic

15/05/2012

This article was translated by an automatic translation system, and was therefore not reviewed by people.


 




The National Health Surveillance Agency (ANVISA) published on Monday (14/5) in the Official Gazette (DOU), a resolution which determines the seizure and destruction throughout the country, all lots fake drug-Desobesi M.

The counterfeit version of Desobesi-M had the following identification: lots Fab set/11 L1100285 - Set/13 Val, Val Mar/14 L1100090, L1100090 Fab Mar/11 - Mar/13 Val, L1103972 Fab Jun / 11 - Val Val Mar/13 Jun/13 and L1100090.

The measure of seizure and destruction of the drug was determined by ANVISA after the forgeries were identified Desobesi-M that resemble the original product, manufactured by Aché Pharmaceutical Laboratories Ltd. until December 2011. The counterfeit product even has the same numbering of the original batch.

Although counterfeiting of drugs is the reason for the decision to seize, the record of Desobesi-M is canceled by the ANVISA from the day December 11, 2011, for determination of the Board Resolution (RDC) 52, 2011.

The RDC 52/2011 prohibits the manufacture, import, export, distribution, handling, prescribing, dispensing, the dispensing, sale and use of drugs or drug formulations containing substances amfepramone, fenproporex and mazindol, principles assets classified as amphetamine-type anorectics.



Press / Anvisa

Source: ANVISA

Our news are taken in full of our partner sites. For this reason, we can not change the content of these up in case of typing errors.

This article was translated by an automatic translation system, and was therefore not reviewed by people.

Important:
The JurisWay site does not interfere in the work provided by doctrine, why only reflect the opinions, ideas and concepts of their authors.


  Subjects list
 
  Copyright (c) 2006-2009. JurisWay - All rights reserved.